Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Heart Disease Clinical Trials

A listing of Heart Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (2067) clinical trials

A research study is comparing the effects of an investigational combination therapy to the effects of these medications alone, and compared to placebo. This research study may be an option if you: Are at least 18 years of age Are on a maximally tolerated statin therapy and have been told ...

Phase N/A

A clinical trial seeking patients for a research study for the treatment of Hypertriglyceridemia. The purpose of this study is test the safety and effectiveness of a study drug to a comparator and that of a placebo. Volunteers may receive compensation up to $625 for time, travel and study-related medical ...

Phase N/A

A research study is comparing the effects of an investigational combination therapy to the effects of these medications alone, and compared to placebo. This research study may be an option if you: Are at least 18 years of age Are on a maximally tolerated statin therapy and have been told ...

Phase N/A

People with heart failure are asked to participate in a research study being conducted by Montefiore Medical Center. The MANAGE-HF study intends to evaluate whether proper clinical integration of HeartLogic, a remote monitoring diagnostic feature in Boston Scientific ICDs and CRT-Ds, can reduce heart failure hospitalization or other heart failure ...

Phase N/A

Cardiology/Vascular Diseases

Phase N/A

A global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients.

Phase N/A

A research study is evaluating the effects of an investigational study medication for heart failure in patients with iron deficiency.

Phase N/A

To evaluate the safety and efficacy of a once daily oral medication compared to a placebo, in patients with chronic Heart Failure with preserved Ejection Fraction.

Phase

To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on the time to cardiovascular (CV) death or first HF (Heart Failure) event, whichever occurs first, in subjects with chronic HF with reduced ejection fraction (HFrEF) receiving standard of care (SoC) therapy.

Phase N/A

To evaluate the efficacy of the oral soluble guanylate cyclase (sGC) stimulator MK-1242 (vericiguat) in comparison to placebo on a background of standard of care in increasing the time to first occurrence of the composite of CV death or HF hospitalization in subjects with HFrEF.

Phase N/A